Suchbegriff: Oral-b in Rubrik News
La acción de Novo Nordisk se mantiene en su media de 50 ...
Novo Nordisk: la ciencia respalda a CagriSema, pero el precio no levanta cabeza
boerse-global.de, 09.06.26 10:21 UhrResultados positivos de CagriSema no elevan la cotización. ...
Novo Nordisk: la ciencia avanza, pero el mercado pide pruebas comerciales
boerse-global.de, 09.06.26 10:16 UhrNovo Nordisk's stock languishes near 52-week lows death ...
Novo Nordisk’s REIMAGINE Data Buoys Pipeline, but Shares Stay Grounded by Competitive Reality
boerse-global.de, 09.06.26 06:45 UhrBlend-a-med toothpaste is a fluoride-based paste from Procter ...
Blend-a-med toothpaste: what US users should know
ad-hoc-news.de, 08.06.26 23:23 UhrMonjuvi offers a targeted antibody treatment option for ...
How Monjuvi Helps Treat Relapsed or Refractory DLBCL
ad-hoc-news.de, 08.06.26 23:15 UhrNovo Nordisk acumula caída del 44% en 12 meses. Pese a ...
Novo Nordisk amplía su perímetro con una alianza en Oriente Próximo mientras la acción batalla por encontrar un rumbo claro
boerse-global.de, 08.06.26 20:22 UhrDr. Dre quietly sets the stage for a pivotal new chapter ...
Dr. Dre returns to the spotlight with long-awaited new era
ad-hoc-news.de, 08.06.26 19:02 UhrA lavish new box set and streaming upgrades are putting ...
Ray Charles returns to the spotlight with rare new box set
ad-hoc-news.de, 08.06.26 18:38 UhrNovo Nordisk presenta datos clínicos sólidos en ADA pero ...
Novo Nordisk refuerza su estrategia con datos de longevidad y una alianza en Emiratos, mientras la acción sigue a la espera
boerse-global.de, 08.06.26 18:14 UhrNovo Nordisk unveils longevity and aesthetics strategy at ...
Novo Nordisk Maps Out a Future Beyond Weight Loss, but Investors Are Counting the Days to 2027
boerse-global.de, 08.06.26 18:13 UhrR.E.M. quietly reunite after years away sparking a new chapter ...
R.E.M. reunion lights up 2026: band breaks long silence
ad-hoc-news.de, 08.06.26 17:26 UhrOrion Oyj drew fresh investor attention after presenting ...
Orion Oyj stock (FI0009014377): Pharma group in focus after ASCO data and solid start to 2026
ad-hoc-news.de, 08.06.26 16:44 UhrNovo Nordisk reveals new semaglutide data at ADA including ...
Novo Nordisk’s Semaglutide Data Piles Up, Yet Stock Remains Unmoved
boerse-global.de, 08.06.26 15:53 UhrThe Procter & Gamble Company recently reported solid quarterly ...
The Procter & Gamble Company stock (US7427181091): defensive consumer giant after latest results and dividend move
ad-hoc-news.de, 08.06.26 12:24 UhrA deluxe 40th anniversary ‘Purple Rain’ reissue new ...
Prince estate opens ‘Purple Rain’ vault for 40th anniversary
ad-hoc-news.de, 07.06.26 15:35 UhrMetallica’s M72 World Tour is roaring back through US ...
Metallica bring M72 thunder back to US stadiums
ad-hoc-news.de, 07.06.26 13:26 UhrPortishead’s surprise live return and studio hints have ...
Portishead return sparks hope for new music era
ad-hoc-news.de, 07.06.26 13:21 UhrNovo Nordisk presenta datos de Amycretin con reducción ...
Novo Nordisk: entre los brotes verdes de Zenagamtide y el lastre de CagriSema
boerse-global.de, 07.06.26 11:44 UhrNovo Nordisk presentó en ADA 2025 el estudio COMPETE SWITCH ...
Novo Nordisk defiende su territorio: los datos de COMPETE SWITCH y Zenagamtid refuerzan el arsenal frente a la presión del mercado
boerse-global.de, 07.06.26 05:03 UhrNovo Nordisk shares drop 4.57% 47% off high yet pipeline ...
Novo Nordisk’s Combination Strategy Takes Center Stage as Pipeline Advances, Shares Stay Muted
boerse-global.de, 06.06.26 20:43 UhrMonjuvi offers a targeted option for adults with relapsed ...
Monjuvi brings targeted lymphoma treatment option to US adults
ad-hoc-news.de, 06.06.26 20:07 UhrBlend-a-med toothpaste is a long-running Procter & Gamble ...
Blend-a-med toothpaste: what US buyers should know
ad-hoc-news.de, 06.06.26 19:08 UhrNovo Nordisk's stock remains under pressure from US pricing ...
Novo Nordisk's Drug Arsenal Expands with Pill Milestone and Deals, but Regulatory Fog Holds the Stock Down
boerse-global.de, 06.06.26 17:58 UhrPese a la caída del 27% en el último mes Assembly Biosciences ...
Assembly Biosciences: el desplome del 17% oculta una hoja de ruta clínica que apuntala el 87% de potencial alcista
boerse-global.de, 06.06.26 17:14 UhrPese al desplome bursátil del 16 4% en 2026 Novo Nordisk ...
Novo Nordisk refuerza su arsenal terapéutico con Zenagamtide y Veru, pero la cotización sigue sin reaccionar
boerse-global.de, 06.06.26 15:15 UhrNovo Nordisk shares slip 4.35% as pipeline advances—Zenagamtide ...
Novo Nordisk's Pipeline Humming, but Shares Remain Stuck in Neutral
boerse-global.de, 06.06.26 15:05 UhrArm & Hammer Zahnpasta setzt auf Natron zur sanften Reinigung ...
Arm & Hammer Zahnpasta: Eigenschaften, Einsatz und Alternativen
ad-hoc-news.de, 06.06.26 12:16 UhrNovo Nordisk mostró en ADA datos mixtos: zenagamtide eficaz ...
Novo Nordisk: el éxito de Zenagamtide y la alianza con Veru no logran disipar la sombra de CagriSema
boerse-global.de, 06.06.26 12:15 UhrNovo Nordisk stock fell 4.4% on CagriSema's weight loss ...
Novo Nordisk's Mixed Bag: Zenagamtide Data Delights, CagriSema Stumbles, Veru Deal Emerges
boerse-global.de, 06.06.26 12:14 UhrAssembly Biosciences stock fell 27% to $22.82 below moving ...
Assembly Biosciences Slides 27% in a Month, Oversold Yet Still Searching for a Floor
boerse-global.de, 06.06.26 06:43 UhrRobben Island near Kapstadt in Sudafrika is more than Nelson ...
Robben Island: Inside Cape Town’s Island of Memory
ad-hoc-news.de, 06.06.26 06:16 UhrEl valor pierde un 27% en un mes y cotiza en sobreventa. ...
Assembly Biosciences: la sobreventa técnica no frena la sangría mientras el mercado aguarda el veredicto de Gilead
boerse-global.de, 06.06.26 03:02 UhrNovo Nordisk faces pivotal week with oral Wegovy's first ...
Novo Nordisk's High-Stakes Week: CagriSema Data and Oral Wegovy's UAE Launch Test Investor Patience
boerse-global.de, 05.06.26 20:44 UhrNovo Nordisk unveils first Phase 3 CagriSema diabetes results ...
Novo Nordisk Pins Hopes on CagriSema Data and Wegovy Combo Study to Reverse Stock's Slide
boerse-global.de, 05.06.26 17:09 UhrNovo Nordisk A/S shares traded higher on Nasdaq Copenhagen ...
Novo Nordisk A/S stock (DK0062498333): shares advance ahead of ADA data and R&D update
ad-hoc-news.de, 05.06.26 07:13 UhrERA 2026: HighTide Therapeutics Presents New Findings Supporting ...
HONG KONG, June 5, 2026 - (ACN Newswire) - HighTide Therapeutics, Inc.
japancorp.net, 05.06.26 06:02 UhrNovo Nordisk navigates oral Wegovy rollout in UAE US Medicare ...
With Oral Wegovy in the Gulf and Medicare on the Horizon, Novo Nordisk Awaits Its Pipeline Verdict
boerse-global.de, 04.06.26 15:13 UhrNovo Nordisk navigates a critical month with Medicare's ...
Novo Nordisk Juggles Gulf Expansion, Medicare Entry and Make-or-Break Clinical Results in Bid to Rekindle Investor Confidence
boerse-global.de, 04.06.26 13:31 UhrDie Colgate-Palmolive Co-Aktie zeigt sich an der NYSE nach ...
Colgate-Palmolive Co-Aktie (US1941621039): Kurs reagiert in New York auf Marktdaten und Branchenumfeld
ad-hoc-news.de, 04.06.26 11:06 UhrNovo Nordisk A/S shares on Nasdaq Copenhagen traded slightly ...
Novo Nordisk A/S stock (DK0062498333): Danish pharma heavyweight steadies after recent pullback
ad-hoc-news.de, 04.06.26 08:24 UhrNew semaglutide kidney data boosts pipeline confidence but ...
Novo Nordisk at a Crossroads: Pipeline Hopes Meet Pricing Pressures Ahead of ADA and Medicare Shift
boerse-global.de, 04.06.26 08:20 UhrNovo Nordisk expande su píldora oral Wegovy a Emiratos ...
Novo Nordisk: el ojo del mercado está en la ADA, pero la píldora ya conquista el Golfo
boerse-global.de, 04.06.26 06:50 UhrNovo Nordisk presenta CagriSema en ADA Medicare cubrirá ...
Novo Nordisk: ciencia, Medicare y la píldora se cruzan en una semana decisiva
boerse-global.de, 04.06.26 04:52 UhrFrancia reembolsa Wegovy para obesidad severa (15 junio) ...
Novo Nordisk: la cobertura de Wegovy se retira en EE.UU. mientras Francia abre sus puertas
boerse-global.de, 03.06.26 19:42 UhrOral Wegovy sets record US prescriptions while Cigna drops ...
Novo Nordisk Navigates Conflicting Signals as Wegovy Pill Surges But Employer Reimbursement Tightens
boerse-global.de, 03.06.26 19:41 UhrFrancia financia Wegovy la EMA avala dos nuevas variantes ...
Novo Nordisk: dos continentes, un mismo desafío: la expansión de Wegovy choca con el escepticismo bursátil
boerse-global.de, 03.06.26 18:11 UhrNovo Nordisk A/S shares in Denmark trade against the backdrop ...
Novo Nordisk A/S stock (DK0060534915): Wegovy pill launch in UAE highlights global obesity-care push
ad-hoc-news.de, 03.06.26 17:16 UhrA new “In Utero” box a major documentary and fresh streaming ...
Nirvana’s legacy returns: new reissues and film fuel a grunge revival
ad-hoc-news.de, 03.06.26 17:11 UhrFrancia financia Wegovy desde junio y el comprimido oral ...
Novo Nordisk abre dos frentes clave: reembolso en Francia y lanzamiento de la píldora en Oriente Medio
boerse-global.de, 03.06.26 16:32 UhrNovo Nordisk faces pivotal week at ADA with CagriSema data ...
CagriSema Data and Commercial Headwinds Converge for Novo Nordisk in Critical June Week
boerse-global.de, 03.06.26 13:32 UhrLa farmacéutica danesa presenta resultados de su combinación ...
Novo Nordisk: el pulso de CagriSema y la apertura de Europa marcan la agenda del verano
boerse-global.de, 03.06.26 13:31 UhrFrance becomes first EU country to reimburse weight-loss ...
Novo Nordisk’s European Reimbursement Milestone and Pipeline Advances Offer a Dual Cue for Skeptical Markets
boerse-global.de, 03.06.26 08:51 UhrNovo Nordisk cae en bolsa pese a éxito de ventas y recompra ...
Novo Nordisk: la brecha entre las cifras operativas y el castigo bursátil se someterá al veredicto de la ADA
boerse-global.de, 03.06.26 04:49 UhrA pesar de vender 2 millones de recetas en EE.UU. la acción ...
Novo Nordisk: la autocompra y la ciencia se citan en Nueva Orleans mientras la acción languidece
boerse-global.de, 03.06.26 04:49 UhrNovo Nordisk unveils CagriSema Phase 3 results at ADA next ...
Buybacks Offer Support, But Novo Nordisk’s Path Hinges on ADA Data
boerse-global.de, 03.06.26 04:47 UhrNovo Nordisk's oral obesity therapy drives 2M prescriptions ...
Novo Nordisk Bets on Buybacks and Pipeline Data as Prescription Boom Meets Washington Pricing Pressure
boerse-global.de, 02.06.26 21:11 UhrNovo Nordisk pierde exclusividad en CVS; Eli Lilly iguala. ...
Novo Nordisk: el privilegio de Wegovy expira en CVS mientras Medicare se abre como contrapeso
boerse-global.de, 02.06.26 19:42 UhrNovo Nordisk loses preferred CVS Caremark status for Wegovy ...
Novo Nordisk’s Adiposity Franchise Under Siege as CVS Levels the Playing Field and US Pricing Rules Tighten
boerse-global.de, 02.06.26 19:42 UhrMedicare incluye Wegovy desde julio 2026 pero CVS equipara ...
Novo Nordisk: el Medicare se abre, el formulario se iguala y la ADA marcará el próximo pulso
boerse-global.de, 02.06.26 17:32 UhrDespite two CHMP recommendations for oral and high-dose ...
Novo Nordisk’s Bittersweet Victory: EU Backs New Wegovy Forms as Shares Slump and Competition Intensifies
boerse-global.de, 02.06.26 17:32 UhrEl fabricante danés pierde el blindaje comercial de Wegovy ...
Novo Nordisk: el asedio de Lilly y la puerta al Medicare redefinen el escenario de Wegovy
boerse-global.de, 02.06.26 15:12 UhrNovo Nordisk partners with NOVI Health in Singapore cuts ...
Novo Nordisk Forges Singapore Weight-Loss Alliance as US Pricing Reset and Buyback Program Diverge
boerse-global.de, 02.06.26 15:12 UhrLa acción de Novo Nordisk cae un 46% desde máximos pero ...
Novo Nordisk: Wegovy pierde su blindaje comercial mientras la ADA dicta sentencia sobre CagriSema
boerse-global.de, 02.06.26 13:52 UhrAs commercial pressures mount from Lilly rivals and patent ...
Novo Nordisk’s Pipeline Verdict Looms as Wegovy’s Formulary Edge Crumbles and Buybacks Fall Short
boerse-global.de, 02.06.26 13:42 UhrNovo Nordisk spent €4.7B on share buybacks but stock is ...
Novo Nordisk’s Buyback Program Hits 4.7 Billion Kronen as ADA Conference Holds the Next Catalyst
boerse-global.de, 02.06.26 11:31 UhrNovo Nordisk enfrenta la pérdida de exclusividad en CVS ...
Novo Nordisk: nueva era de competencia y acceso masivo, la ADA decidirá el rumbo
boerse-global.de, 02.06.26 10:50 UhrNovo Nordisk's Wegovy loses CVS exclusivity faces product-liability ...
Novo Nordisk Heads to New Orleans With Pipeline Hopes as Headwinds Multiply
boerse-global.de, 02.06.26 08:32 UhrEU approves higher-dose Wegovy but CVS Caremark favors Eli ...
Amid Wegovy's EU Endorsement, Novo Nordisk Grapples with a Rising Tide of Litigation and a Critical US Pharmacy Decision
boerse-global.de, 02.06.26 06:24 UhrLa farmacéutica danesa enfrenta oleada de demandas por ...
Novo Nordisk: la nueva dosis de Wegovy gana impulso regulatorio en plena tormenta judicial y comercial
boerse-global.de, 02.06.26 06:21 UhrNovo Nordisk s oral Wegovy gets UAE approval, but US pricing pressure mounts as CVS adds Lilly ...
Novo Nordisk's Contradictory Landscape: Oral Wegovy Wins a Second Market as US Headwinds Intensify
boerse-global.de, 02.06.26 04:52 UhrLa farmacéutica danesa pierde un 46% desde su máximo anual ...
Novo Nordisk: la aprobación de Wegovy oral en Emiratos no logra disipar las nubes judiciales y comerciales
boerse-global.de, 02.06.26 04:51 UhrNovo Nordisk shares tumble 46% from peak after CVS strips ...
Novo Nordisk Faces a Pincer Movement: Legal Headwinds and a Crumbling GLP-1 Fortress
boerse-global.de, 02.06.26 04:00 UhrCVS elimina exclusividad de Wegovy Novo Nordisk recompra ...
Novo Nordisk: la semana de la ADA decidirá si los datos de CagriSema compensan el golpe comercial
boerse-global.de, 01.06.26 20:22 UhrCVS Caremark revokes Wegovy's preferred status on formulary ...
Novo Nordisk’s Balancing Act: Weighing a Lost CVS Advantage Against a Make-or-Break Data Readout
boerse-global.de, 01.06.26 20:12 UhrPese al éxito inicial de Wegovy oral con 146.000 prescripciones ...
Novo Nordisk: recetas récord y recompra no bastan mientras el mercado aguarda los datos de CagriSema
boerse-global.de, 01.06.26 18:42 UhrNovo Nordisk s oral Wegovy prescriptions outpace Eli Lilly ...
Novo Nordisk's Summer of Reckoning: Prescription Dominance Meets Pipeline Verdict
boerse-global.de, 01.06.26 18:42 UhrLa farmacéutica danesa mantiene su programa de recompra ...
La doble señal de Novo Nordisk: recompra de acciones y cita con la ADA
boerse-global.de, 01.06.26 17:02 UhrDanish pharma giant unveils REIMAGINE Phase 3 results for ...
Novo Nordisk Juggles Share Buybacks and Pipeline Hype as CagriSema Data Approaches
boerse-global.de, 01.06.26 17:02 UhrCVS Caremark drops Wegovy's exclusive status boosting Eli ...
Novo Nordisk Navigates a Crucial Week as Wegovy's Formulary Edge Vanishes and CagriSema Data Beckon
boerse-global.de, 01.06.26 15:32 UhrLa farmacéutica danesa presenta 40 abstracts en la ADA ...
Novo Nordisk: el fin de la exclusividad de Wegovy y la cita de la ADA ponen a prueba el horizonte de la acción
boerse-global.de, 01.06.26 15:31 UhrNovo Nordisk A/S starts the week in Denmark with investor ...
Novo Nordisk A/S stock (DK0062498333): ADA obesity data and European Wegovy decisions keep focus on GLP-1 pipeline
ad-hoc-news.de, 01.06.26 08:35 UhrFrance will publicly reimburse Wegovy and Mounjaro and EMA ...
Novo Nordisk's European Breakthrough Tempered by Growing Generics Threat in Brazil and Beyond
boerse-global.de, 01.06.26 06:42 UhrFrancia reembolsará Wegovy y Mounjaro al 65-100% desde ...
Novo Nordisk: Europa allana el camino con el reembolso de Wegovy mientras Brasil abre la puerta a los genéricos
boerse-global.de, 01.06.26 06:40 UhrLa farmacéutica danesa reduce un 19% el precio de Wegovy ...
Novo Nordisk: entre recortes de precios en Europa y la llegada de genéricos en Brasil, la acción busca un nuevo equilibrio
boerse-global.de, 01.06.26 04:31 UhrNovo Nordisk cuts Wegovy prices in Portugal by 19% while ...
Novo Nordisk Navigates a Tightrope of Price Cuts and Patent Erosion as GLP-1 Competition Intensifies
boerse-global.de, 01.06.26 04:31 UhrGorillaz fans spot fresh studio clips new artwork and subtle ...
Gorillaz spark comeback rumors with studio teasers and tour hints
ad-hoc-news.de, 01.06.26 04:12 UhrLa acción de Novo Nordisk se mantiene plana mientras enfrenta ...
Novo Nordisk: fin de la exclusividad de Wegovy en EE.UU. y primer genérico de Ozempic en Brasil
boerse-global.de, 01.06.26 03:03 UhrCVS Caremark ends Wegovy's exclusivity; Brazil approves ...
Novo Nordisk Faces a Two-Front Assault as CVS Drops Wegovy Exclusivity and Brazil Approves a Cheaper Rival
boerse-global.de, 01.06.26 03:02 UhrLa acción de Novo Nordisk cae un 35 7% interanual. Brasil ...
Novo Nordisk: patentes, competencia local y una nueva definición clínica sacuden el horizonte de la acción
boerse-global.de, 01.06.26 01:20 UhrA new wave of tributes reissues and education projects is ...
Ray Charles legacy marks major 2026 milestone in US music
ad-hoc-news.de, 01.06.26 00:46 UhrAs Nirvana’s Bleach hits 35 a new deluxe reissue fresh ...
Nirvana’s ‘Bleach’ turns 35: how a scrappy debut quietly changed rock
ad-hoc-news.de, 01.06.26 00:34 UhrMonjuvi is a CD19-directed antibody therapy for adults with ...
Monjuvi brings targeted lymphoma therapy closer to first-line use
ad-hoc-news.de, 31.05.26 18:59 UhrNovo Nordisk A/S shares remain in the spotlight after strong ...
Novo Nordisk A/S stock (DK0060534915): technical picture in focus after GLP-1 news flow and US price gains
ad-hoc-news.de, 31.05.26 16:17 UhrNovo Nordisk A/S shares made modest gains into the new week ...
Novo Nordisk A/S stock (DK0062498333): shares edge higher as investors eye obesity franchise momentum
ad-hoc-news.de, 31.05.26 08:23 UhrNovo Nordisk presenta datos de fase III de CagriSema en ...
Novo Nordisk afronta la semana más decisiva del año: datos, presión comercial y una valoración a examen
boerse-global.de, 31.05.26 03:22 UhrNovo Nordisk shares slide 35% in 12 months as market awaits ...
Novo Nordisk Enters a Pivotal Week: Pipeline Data Meets a Skeptical Market
boerse-global.de, 31.05.26 03:22 UhrLa tableta de semaglutida logra 18.410 recetas en su primera ...
Novo Nordisk: la píldora oral de Wegovy firma un debut arrollador mientras Jefferies frena el entusiasmo
boerse-global.de, 30.05.26 22:20 UhrNovo Nordisk’s Oral Wegovy Outpaces Eli Lilly Fivefold, Yet Jefferies Stays on the Sidelines
boerse-global.de, 30.05.26 22:01 UhrLa aprobación en India de Wegovy para adolescentes contrasta ...
